Evidence map›Paper›PMID 41088895›Full record

ArticleNeurodegenerative disease management2026

Exploring the mid-term impact of telemonitoring in Parkinson's disease: insights from adoption into clinical practice.

Foivos S Kanellos, Eleni Kosmidi, Georgios Rigas, Ermioni Petkou, Yannis V Simos, Lampros Lakkas, Dimitrios Peschos, Spyridon Konitsiotis, Konstantinos I Tsamis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurodegenerative disease management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Foivos S KanellosDepartment of Physiology, Faculty of Medicine, School of Health Sciences, University of loannina, Ioannina, Greece.ORCID 0000-0002-5373-6236
Eleni KosmidiDepartment of Physiology, Faculty of Medicine, School of Health Sciences, University of loannina, Ioannina, Greece.
Georgios RigasResearch and Development Department, PD Neurotechnology Ltd., Ioannina, Greece.
Ermioni PetkouDepartment of Physiology, Faculty of Medicine, School of Health Sciences, University of loannina, Ioannina, Greece.ORCID 0000-0003-3334-8989
Yannis V SimosDepartment of Physiology, Faculty of Medicine, School of Health Sciences, University of loannina, Ioannina, Greece.
Lampros LakkasDepartment of Physiology, Faculty of Medicine, School of Health Sciences, University of loannina, Ioannina, Greece.
Dimitrios PeschosDepartment of Physiology, Faculty of Medicine, School of Health Sciences, University of loannina, Ioannina, Greece.
Spyridon KonitsiotisDepartment of Neurology, University Hospital of Ioannina, Ioannina, Greece.
Konstantinos I TsamisDepartment of Physiology, Faculty of Medicine, School of Health Sciences, University of loannina, Ioannina, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRoutine clinical evaluations offer limited insight into daily variability and disease progression in Parkinson's disease (PD). While wearable devices are increasingly used to improve patient monitoring, evidence of their effectiveness remains scarce.

objectiveTo assess the efficacy of integrating a telemonitoring system into standard clinical procedures, highlighting its role in enabling efficient, patient-centered treatment adjustments.

methodsThirty-five PD patients were monitored for 6 months using a telemonitoring device alongside standard care. Disease progression was assessed via MDS-UPDRS part III (UPDRS-p3) and device-reported outcomes (dUPDRS) at baseline and follow-up. Physicians provided feedback on telemedicine utility.

resultsUPDRS-p3 scores improved by 1.9-5.63 points. Changes in UPDRS-p3 strongly correlated with dUPDRS (

conclusionTelemonitoring supported clinical decisions, detected subtle symptom changes, and offered valuable insights for improving motor symptoms and patient management.

Indexed as

Parkinson DiseaseAgedDisease ProgressionFemaleHumansMaleMiddle AgedTelemedicineWearable Electronic Devicesclinical effectivenessintegrationParkinson’s diseaseParkinson’s disease progressiontelemonitoring

Identifiers

PMID41088895
PMCPMC13011622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.